The global market for cannabidiol (CBD) is expected to increase by over 1,100% between 2022 and 2032, according to a new report.
The report by Emergen Research found that as of the end of 2022, the global CBD market was valued at $3.86 Billion. It’s expected to register “a rapid revenue CAGR [compound annual growth rate] of 28.3% during the forecast period”, to reach a value of $46 billion by 2032
Key factors propelling this growth “include the rising preference for cannabis extracts, changing regulatory landscapes, and a surge in retailers offering CBD-based products”, states the report. “CBD, a natural compound in the cannabis plant, has gained significant traction for its potential health benefits, including treating chronic pain, anxiety, inflammation, and insomnia. FDA approval for epilepsy treatment underscores its therapeutic potential.”
Continue reading